Researchers
Galbraith, Matthew D PHD
University of Colorado Denver
INCLUDE Grants
The INCLUDE Project Down Syndrome Biorepository (DS-Biorepository)
Grant Number
U24AG092191
NIH Institute
NIA
Mechanism
U24
People with Down syndrome display increased risk of developing diverse co-occurring conditions, but the mechanisms driving this unique clinical profile are yet to be defined. This project will develop a biobanking research infrastructure that could support a wide range of investigations by a multidisciplinary team of researchers through the collection of diverse biospecimens using harmonized protocols. These activities will greatly accelerate the pace of discoveries benefiting persons with Down syndrome.
The INCLUDE Data Coordinating Center
Grant Number
U2CHL156291
NIH Institute
NHLBI
Mechanism
U2C
- Carroll, Robert J
- Galbraith, Matthew D
- DiGiovanna, Jack
- Espinosa, Joaquin M
- Ferretti, Vincent
- Resnick, Adam Cain
- O’Connor, Brian
- Guinney, Justin
- Haendel, Melissa A
PROJECT NARRATIVE – Overall
People with Down syndrome are strongly predisposed to develop a wide range of co-occurring conditions that
shorten their lifespan and decrease their quality of life, such as Alzheimer’s disease, congenital heart disease,
autoimmune disorders, and diverse neurological conditions. The proposed activities under this project seek to
further develop a world-class resource for collaborative discovery, data sharing, data access, and analysis that
would enable novel investigations of DS across the lifespan, thus paving the way for a precision medicine
approach to DS. Furthermore, this resource and associated platforms will also have broader impacts by
empowering physicians, educators, government officials, and advocates with the tools required to elicit evidence-
based transformative action in the clinic, the classroom, the government, and society at large.
Trisomy 21 Model Atlas
Grant Number
R24OD035579
NIH Institute
OD
Mechanism
R24
Down syndrome (DS), the genetic condition caused by triplication of chromosome 21 (T21), is the most common chromosomal abnormality and a leading cause of intellectual and developmental disability. Although it is accepted that T21 causes genome-wide dysregulation of gene expression programs, little is known about how T21 affects gene expression across different tissues and organs, and how these effects contribute to the developmental and clinical hallmarks of DS. To address this knowledge gap, this proposal aims to generate a comprehensive atlas of tissue-specific gene expression changes caused by T21, matched to detailed metrics of organ development and architecture.
Publications
-
Nature communications
An integrated multi-omic natural history study of human development, sexual dimorphism, and the effects of trisomy 21. -
Annals of clinical and translational neurology
Evidence of blood-brain barrier dysfunction and CSF immunoglobulin synthesis in Down Syndrome Regression Disorder. -
eLife
Mediator kinase inhibition suppresses hyperactive interferon signaling in Down syndrome. -
eLife
JAK inhibition decreases the autoimmune burden in Down syndrome. -
Science advances
Integrated analysis of immunometabolic interactions in Down syndrome. -
Cell reports
Multimodal analysis of dysregulated heme metabolism, hypoxic signaling, and stress erythropoiesis in Down syndrome. -
Nature communications
Variegated overexpression of chromosome 21 genes reveals molecular and immune subtypes of Down syndrome.